James Slattery
Chief Executive Officer
James Slattery is the founder and Chief Executive Officer of Millennium Laboratories. Because of his own direct experience with people who suffer with chronic pain, he founded Millennium Laboratories and established the company's two-fold mission:
- · To help alleviate human suffering through leading research and education that increases industry and public awareness of pain management.
- · To transform the science of toxicology from a forensics model to improving clinical care for people in pain.
Among his many entrepreneurial accomplishments, Mr. Slattery was recognized with the Ernst & Young Entrepreneur of the Year 2011 San Diego region award for entrepreneurial excellence. Prior to Millennium Laboratories, he achieved success in real estate development and broadcast communications, creating the first satellite network in the United States which he later sold to a Fortune 500 broadcast companyy.
Mr. Slattery served for eight years as the Commissioner of Aeronautics for the State of Massachusetts. He continues to utilize his aviation background in the service of others through his role as a mission pilot for Angel Flight West, a non-profit organization that provides free medical assistance flights in the thirteen Western states. Mr. Slattery holds a Bachelor's degree from the University of Massachusetts.
Howard Appel
President
Howard Appel is the President of Millennium Laboratories. Prior to his promotion to President, he served Millennium as the company’s Chief Financial Officer. As President, Mr. Appel's responsibilities include oversight of the company’s daily operations and implementation of its annual growth initiatives. Through his dual role as senior management and Board of Directors member, he also directs the company’s strategic initiatives and long term planning.
Mr. Appel has more than twenty-five years of experience as a Chief Executive Officer, Chief Financial Officer and Certified Public Accountant. Prior to joining Millennium, he was CEO of a boutique financial advisory. He also served as Chief Financial Officer of Laffer Associates for 17 years. Mr. Appel has served on the Board of Directors of a number of publicly and privately held firms including Millennium. He received his Bachelor of Science degree in Business and Accounting from California State University, Chico.
Martin Price
General Counsel
Martin Price serves as General Counsel for Millennium Laboratories. He is responsible for oversight of all legal affairs of the company. He is involved in the company's continued expansion throughout the United States and in its development of strategic alliances and partnerships.
Before joining Millennium Laboratories, Mr. Price acted as outside counsel to the company while a Partner with the international law firm Hogan Lovells US LLP. Previously he was an associate with the international law firm Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates and a law clerk to the Honorable W. Curtis Sewell (ret.) of the U.S. District Court for the Eastern District of Virginia.
Mr. Price has a prolific record of legal experience that includes serving as lead trial counsel on behalf of major U.S. and international corporations in defending class actions, government investigations, civil litigation, and prosecuting litigation against competitors. He has handled matters ranging from constitutional challenges to federal Medicare/Medicaid programs to clinical drug-testing laboratory litigation involving misappropriation of trade secrets, false and deceptive advertising, violation of non-competition/solicitation agreements, and unfair trade practices. His substantial healthcare expertise covers the full spectrum of federal and state compliance matters for clinical testing laboratories, including the federal Stark and anti-kickback laws, HIPAA and Hi-Tech and various state rules and regulations.
As an adjunct professor of law at the George Washington University Law School, Mr. Price taught numerous courses and was also the Co-chair of the Hogan Lovells Litigation Department's associate training program. He holds dual B.A. degrees, with honors, from the George Washington University and a M.A. degree from Duke University. He received his J.D. with high honors from the George Washington University Law School, where he served as a senior editor of the George Washington University Law Review.
David Cohen
Chief Operating Officer
David Cohen is the Chief Operating Officer of Millennium Laboratories. His responsibilities include new business analysis and development to expand the company's core business. As COO, he also has oversight of Millennium's legislative initiatives and community and corporate outreach programs. He brings valuable experience to the company in negotiation, fund raising, SEC compliance and investor relations.
In his 28-year career, Mr. Cohen has been Controller, Chief Financial Officer and later Executive Vice President of a $500 million dollar real estate conglomerate operating in 38 states and the commonwealth territories. He has twice served as Chief Financial Officer of Public Entities. His experience encompasses varied industries including biotech, international trade, banking, telecommunications and high tech manufacturing. David has been involved with several start-ups and successfully navigated difficult turnaround situations. His reputation as a skilled negotiator is well-earned – he has raised more than $35 million for specific projects in private and public offerings.
Mr. Cohen has a Bachelor of Science degree in both Economics and Accounting. He is a Certified Public Accountant and has twice been licensed by the National Association of Securities Dealers (NASD) as a Financial Operations Principal.
Charles Mikel, Ph.D.
Vice President/Chief Scientific Officer
As Vice President/Chief Scientific Officer, Dr. Charles Mikel provides scientific leadership and direction to the laboratory operations and R & D programs at Millennium Laboratories. Dr. Mikel is credited with originating the innovative drug testing methods, sample handling and data processing systems used in our state-of-the-art laboratories.
Prior to joining Millennium Laboratories at its inception, Dr. Mikel was a founding scientist at Chembridge Research Laboratories (CRL) in San Diego, CA. As a group leader in the contract research medicinal chemistry group at CRL, Dr. Mikel’s research advanced early-stage drug discovery for several leading pharmaceutical companies, including Pfizer, Astra-Zeneca, Merck, Boehringer-Ingelheim and Takada.
Dr. Mikel has published 30+ research papers and holds several U.S. and international patents related to toxicology, medicinal chemistry and combinatorial chemistry. Dr. Mikel has also published several papers on organo-metallic macromolecular catalysts for use in hydrogen-based fuel cells.
Murray Rosenthal, DO, FAPA
Chief Medical Officer
Dr. Murray Rosenthal, a board-certified psychiatrist and Fellow of the American Psychiatric Association, is our Chief Medical Officer. He knows the field of pain management from both the professional and personal side. He is a former chronic pain patient who underwent five major spine surgeries. As Chief Medical Officer, Dr. Rosenthal brings 26 years of diversified experience as a clinician, researcher and consultant to Millennium working with our senior scientific staff to develop educational and research programs that meet the needs of our pain practitioners, their staff and patients. He is available to our network of physicians for lectures, discussions and consultations.
Prior to joining us, Dr. Rosenthal was Senior Medical Director and CEO of California Clinical Trials, an internationally recognized, multi-site, phase 1-4 CNS research group. During his tenure he conducted over 450 clinical trials in all areas of Central Nervous System (CNS) research.
Dr. Rosenthal became board certified in Psychiatry after completing a residency program in Psychiatry at the University of California-San Diego (UCSD) Medical Center. In 2004 he was honored by the American Psychiatric Association by becoming a Fellow.
A recognized industry leader, Dr. Rosenthal has lectured internationally, nationally and locally to colleagues, allied health professionals and the lay public and is published on a wide variety of topics in psychiatry, sleep, pain and medical management of secondary emotional disorders.
Janna Sipes
Senior Vice President, Regulatory Counsel and Chief Compliance Officer
As Millennium Laboratories' Senior Vice President, Regulatory Counsel and Chief Compliance Officer, Janna Sipes is responsible for the oversight of regulatory and compliance matters for the company, including policy development and implementation, legal analysis of industry laws and regulations, compliance training and monitoring, and managed markets contracts. She applies her regulatory and compliance expertise to enhance Millennium's service portfolio as the company continues to grow.
Ms. Sipes has 20 years of experience as in-house counsel in the biotechnology, pharmaceutical and clinical laboratory industries. Her comprehensive background includes positions with both private and public companies.
Before joining Millennium, Ms. Sipes served as Vice President, Legal and Human Resources, and Compliance Officer with Cypress Bioscience where she developed and implemented all compliance programs and oversaw the legal affairs for the company. She held a similar position with Prometheus Laboratories, Inc. Both San Diego-based companies operated CLIA laboratories and marketed pharmaceuticals which complemented their diagnostic services.
Ms. Sipes has served on the Board of Directors for three non-profit organizations. She holds a B.S. degree from Texas Tech University, Lubbock, Texas and earned her J.D. from Baylor University School of Law, Waco, Texas.
Elizabeth Peacock
Vice President of Sales
Our Vice President of Sales, Elizabeth Peacock brings to Millennium Laboratories more than 20 years of U.S. and international sales management experience in the medical device and pharmaceutical industries. Her pain management medication monitoring marketing experience includes her tenure as the Senior Vice President of Sales and Marketing for Ameritox where she built the company's initial direct sales team.
Ms. Peacock held Vice President level positions in sales and marketing with Baxter Cardiovascular Group and Hancock Jaffe Laboratories, a start-up company manufacturing biological grafts for Cardiovascular and Vascular Bypass and Hemodialysis Access. At Hancock Jaffe she was responsible for developing and implementing the company's entry into the U.S. market following FDA approval including successfully building the company's U.S. sales team. She also served as Director of Sales for Research Medical, Inc.
Educated in Europe, Ms. Peacock attended schools in England, France and Italy. She holds a Bachelor of Arts in Business and Modern Languages from the University of Bath and a Master's degree in Education and German from the University of Reading, both located in the United Kingdom.
-Top of Page-